enVVeno Medical Corp Quarterly Operating Income (Loss) in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
enVVeno Medical Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2017 to Q3 2024.
  • enVVeno Medical Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.17M, a 15.3% decline year-over-year.
  • enVVeno Medical Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$23.4M, a 7.93% increase year-over-year.
  • enVVeno Medical Corp annual Operating Income (Loss) for 2023 was -$25.2M, a 1.23% decline from 2022.
  • enVVeno Medical Corp annual Operating Income (Loss) for 2022 was -$24.9M, a 47.6% decline from 2021.
  • enVVeno Medical Corp annual Operating Income (Loss) for 2021 was -$16.9M, a 84.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$23.4M -$6.17M -$821K -15.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 -$22.6M -$5.45M +$1.36M +20% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 -$23.9M -$5.5M +$1.29M +19% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$25.2M -$6.28M +$182K +2.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$25.4M -$5.35M +$802K +13% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 -$26.2M -$6.81M +$172K +2.46% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 -$26.4M -$6.8M -$1.46M -27.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$24.9M -$6.46M +$2.53M +28.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$27.5M -$6.15M -$3.44M -127% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$24M -$6.99M -$4.6M -193% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-31
Q1 2022 -$19.4M -$5.34M -$2.53M -90% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$16.9M -$8.99M -$4.83M -116% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$12.1M -$2.71M -$785K -40.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 -$11.3M -$2.39M -$840K -54.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$10.4M -$2.81M -$1.3M -86.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 -$9.14M -$4.16M -$1.86M -80.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$7.28M -$1.92M -$88.3K -4.81% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$7.19M -$1.55M +$414K +21.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$7.6M -$1.51M +$73.8K +4.67% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$7.68M -$2.3M -$500K -27.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$7.18M -$1.83M -$346K -23.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$6.83M -$1.96M +$1.15M +37% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$7.98M -$1.58M -$126K -8.65% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-08
Q4 2018 -$7.85M -$1.8M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$1.49M +$325K +17.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 -$3.11M -$1.88M -153% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$1.46M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q3 2017 -$1.81M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$1.23M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.